Bharat Biotech and the University of Sydney Infectious Diseases Institute (Sydney ID) have signed a memorandum of understanding to advance ...

The deal has been approved under the green channel route, wherein a transaction which does not raise any risk of an appreciable adverse eff...

"We will be applying for licenses and (they) should come. If everything goes well, we know by next month (August). You (people) would rathe...

"The company was informed by the USFDA that the agency placed its phase 2/3 immuno-bridging and broadening study for Covaxin (BBV152), OCU-...

CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...

Responding to a question on whether it has come to the notice of the government that COVID-19 vaccine Covaxin used in India is not recognis...

The countries that granted emergency use licences (EUL) include Mexico, Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuel...

In a meeting held on Friday, Covax facility experts from India and other countries recommended approval for the India-developed Covaxin and...

Phase 3 clinical trials of Covaxin by Bharat Biotech International Ltd (BBIL) and ICMR have demonstrated 100% efficacy against severe Covid...

Hailing the Prime Minister for taking the vaccine on the first day, Chairman and Managing Director of Bharat Biotech International Limited ...

The recommendations of the Indian drugs regulator's subject expert committee (SEC) released on Tuesday show that the panel asked Bharat Bio...

Over 60 foreign envoys on Wednesday visited Hyderabad-based leading biotech companies Bharat Biotech and Biological E where they were appri...

Vaccine producer Bharat Biotech International (BBIL) could begin phase I/II human clinical trials for its single-dose intranasal vaccine ca...

"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...

The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National...

Investment banker Avendus has been mandated by ICICI Ventures to find suitors and the initial process has begun, sources in the know said.

Hyderabad-based Bharat Biotech International said it has launched Comvac5, a single shot pentavalent combination vaccine for hepatitis.